Dublin, Feb. 20, 2019 (GLOBE NEWSWIRE) -- The "Global Generic Pharmaceutical Partnering Terms and Agreements 2012-2018: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering.

Global Generic Pharmaceutical Partnering Terms and Agreements 2012 to 2018 report provides a detailed understanding and analysis of how and why companies enter Generic Pharmaceutical partnering deals. This report provides details of the latest Generic Pharmaceutical agreements announced in the life sciences since 2012.

The report takes the reader through a comprehensive review Generic Pharmaceutical deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Generic Pharmaceutical partnering deals.

The report presents financial deal term values for Generic Pharmaceutical deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.

The middle section of the report explores the leading dealmakers in the Generic Pharmaceutical partnering field; both the leading deal values and most active Generic Pharmaceutical dealmaker companies are reported allowing the reader to see who is succeeding in this dynamic dealmaking market.

One of the key highlights of the report is that over 8,000 online deal records of actual Generic Pharmaceutical deals, as disclosed by the deal parties, are included towards the end of the report in a directory format - by company A-Z, stage of development, deal type, therapy focus, and technology type - that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.

In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Whilst many companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.
an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Generic Pharmaceutical technologies and products.

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Generic Pharmaceutical dealmaking

2.1. Introduction
2.2. Generic Pharmaceutical partnering over the years
2.3. Most active Generic Pharmaceutical dealmakers
2.4. Generic Pharmaceutical partnering by deal type
2.5. Generic Pharmaceutical partnering by therapy area
2.6. Generic Pharmaceutical partnering by technology type
2.7. Deal terms for Generic Pharmaceutical partnering
2.7.1 Generic Pharmaceutical partnering headline values
2.7.2 Generic Pharmaceutical deal upfront payments
2.7.3 Generic Pharmaceutical deal milestone payments
2.7.4 Generic Pharmaceutical royalty rates

Chapter 3 - Leading Generic Pharmaceutical deals

3.1. Introduction
3.2. Top Generic Pharmaceutical deals by value

Chapter 4 - Most active Generic Pharmaceutical dealmakers

4.1. Introduction
4.2. Most active Generic Pharmaceutical dealmakers
4.3. Most active Generic Pharmaceutical partnering company profiles

Chapter 5 - Generic Pharmaceutical contracts dealmaking directory

5.1. Introduction
5.2. Generic Pharmaceutical contracts dealmaking directory

Chapter 6 - Generic Pharmaceutical dealmaking by technology type

Chapter 7 - Partnering resource center

7.1. Online partnering
7.2. Partnering events
7.3. Further reading on dealmaking

Appendices

Appendix 1 - Generic Pharmaceutical deals by company A-Z
Appendix 2 - Generic Pharmaceutical deals by stage of development
Appendix 3 - Generic Pharmaceutical deals by deal type
Appendix 4 - Generic Pharmaceutical deals by therapy area
Appendix 5 - Deal type definitions

For more information about this report visit https://www.researchandmarkets.com/research/5mqkj6/global_generic?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: Pharmaceuticals, Generic Drugs 

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.